These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 24137583)
1. The value of Tc-99m tetrofosmin scintimammography in the assessment of P-glycoprotein in patients with breast cancer. Silov G; Erdoğan Z; Özdal A; Tutuş A; Tekin Y; Karaman H; Turhal Ö Hell J Nucl Med; 2013; 16(3):218-22. PubMed ID: 24137583 [TBL] [Abstract][Full Text] [Related]
2. The value of Tc-99m-tetrofosmin scintigraphy in the assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors. Yapar Z; Kibar M; Yapar AF; Uguz A; Ozbarlas S; Gonlusen G Ann Nucl Med; 2003 Sep; 17(6):443-9. PubMed ID: 14575377 [TBL] [Abstract][Full Text] [Related]
3. Imaging recognition of inhibition of multidrug resistance in human breast cancer xenografts using 99mTc-labeled sestamibi and tetrofosmin. Liu Z; Stevenson GD; Barrett HH; Furenlid LR; Wilson DW; Kastis GA; Bettan M; Woolfenden JM Nucl Med Biol; 2005 Aug; 32(6):573-83. PubMed ID: 16026704 [TBL] [Abstract][Full Text] [Related]
4. [Correlation between 99m Tc-tetrofosmin uptake and P-glycoprotein expression in non-small-cell lung cancer]. Tabuenca MJ; Vargas JA; Varela A; Salas C; Durántez A; Ortiz Berrocal J Rev Esp Med Nucl; 1998; 17(6):427-34. PubMed ID: 9873130 [TBL] [Abstract][Full Text] [Related]
5. Using technetium-99m tetrofosmin chest imaging to predict taxol-based chemotherapy response in non-small cell lung cancer but not related to lung resistance protein expression. Shih CM; Shiau YC; Wang JJ; Ho ST; Kao A Lung; 2003; 181(2):103-11. PubMed ID: 12953149 [TBL] [Abstract][Full Text] [Related]
6. Technetium-99m tetrofosmin chest imaging related to p-glycoprotein expression for predicting the response with paclitaxel-based chemotherapy for non-small cell lung cancer. Shiau YC; Tsai SC; Wang JJ; Ho YJ; Ho ST; Kao CH Lung; 2001; 179(4):197-207. PubMed ID: 11891611 [TBL] [Abstract][Full Text] [Related]
7. Clinical validation of the influence of P-glycoprotein on technetium-99m-sestamibi uptake in malignant tumors. Kostakoglu L; Elahi N; Kïratlï P; Ruacan S; Sayek I; Baltalï E; Sungur A; Hayran M; Bekdik CF J Nucl Med; 1997 Jul; 38(7):1003-8. PubMed ID: 9225779 [TBL] [Abstract][Full Text] [Related]
9. Predicting multidrug resistance-related protein and P-glycoprotein expression with technetium-99m tetrofosmin mammoscintigraphy. Liu TJ; Shiau YC; Tsai SC; Wang JJ; Ho ST; Kao A Breast; 2003 Feb; 12(1):58-62. PubMed ID: 14659356 [TBL] [Abstract][Full Text] [Related]
10. To predict response chemotherapy using technetium-99m tetrofosmin chest images in patients with untreated small cell lung cancer and compare with p-glycoprotein, multidrug resistance related protein-1, and lung resistance-related protein expression. Kuo TH; Liu FY; Chuang CY; Wu HS; Wang JJ; Kao A Nucl Med Biol; 2003 Aug; 30(6):627-32. PubMed ID: 12900288 [TBL] [Abstract][Full Text] [Related]
11. Characterization of breast lesion using double phase Tc-99m Tetrofosmin scintimammography: comparison of visual and quantitative analyses. Lee JS; Kim SJ; Kim IJ; Bae YT; Kim YK; Kang YS; Kim DS Eur J Radiol; 2006 Jan; 57(1):76-80. PubMed ID: 16125892 [TBL] [Abstract][Full Text] [Related]
12. Assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy. Taki J; Sumiya H; Asada N; Ueda Y; Tsuchiya H; Tonami N J Nucl Med; 1998 Jul; 39(7):1179-84. PubMed ID: 9669390 [TBL] [Abstract][Full Text] [Related]
13. P-glycoprotein versus MRP1 on transport kinetics of cationic lipophilic substrates: a comparative study using [99mTc]sestamibi and [99mTc]tetrofosmin. Gomes CM; Abrunhosa AJ; Pauwels EK; Botelho MF Cancer Biother Radiopharm; 2009 Apr; 24(2):215-27. PubMed ID: 19409044 [TBL] [Abstract][Full Text] [Related]
14. Determination and prediction of P-glycoprotein and multidrug-resistance-related protein expression in breast cancer with double-phase technetium-99m sestamibi scintimammography. Visual and quantitative analyses. Kim IJ; Bae YT; Kim SJ; Kim YK; Kim DS; Lee JS Oncology; 2006; 70(6):403-10. PubMed ID: 17237619 [TBL] [Abstract][Full Text] [Related]
15. Using technetium-99m-tetrofosmin scan to predict chemotherapy response of malignant lymphomas, compared with P-glycoprotein and multidrug resistance related protein expression. Liang JA; Shiau YC; Yang SN; Lin FJ; Lin CC; Kao A; Lee CC Oncol Rep; 2002; 9(2):307-12. PubMed ID: 11836597 [TBL] [Abstract][Full Text] [Related]
16. Usefulness of technetium-99m tetrofosmin liver imaging to detect hepatocellular carcinoma and related to expression of P-glycoprotein or multidrug resistance associated protein-a preliminary report. Ding HJ; Huang WT; Tsai CS; Chang CS; Kao A Nucl Med Biol; 2003 Jul; 30(5):471-5. PubMed ID: 12831984 [TBL] [Abstract][Full Text] [Related]
17. Association of tumor washout rates and accumulation of technetium-99m-MIBI with expression of P-glycoprotein in lung cancer. Kostakoglu L; Kiratli P; Ruacan S; Hayran M; Emri S; Ergün EL; Bekdik CF J Nucl Med; 1998 Feb; 39(2):228-34. PubMed ID: 9476923 [TBL] [Abstract][Full Text] [Related]
18. Comparison of double phase Tc-99m MIBI and Tc-99m tetrofosmin scintimammography for characterization of breast lesions: Visual and quantitative analyses. Kim IJ; Kim SJ; Kim YK Neoplasma; 2008; 55(6):526-31. PubMed ID: 18999882 [TBL] [Abstract][Full Text] [Related]
19. Technetium-99m tetrofosmin mammoscintigraphy findings related to the expression of P-glycoprotein mediated multidrug resistance. Sun SS; Hsieh JF; Tsai SC; Ho YJ; Kao CH Anticancer Res; 2000; 20(3A):1467-70. PubMed ID: 10928058 [TBL] [Abstract][Full Text] [Related]
20. 99mTc tetrofosmin scintigraphy in acute leukaemia: the relationship between marrow uptake of tetrofosmin and P-glycoprotein and chemotherapy response. Sükan A; Yapar Z; SAhin B; Kara O; Fuat Yapar A; CEtiner S; Kibar M Nucl Med Commun; 2004 Aug; 25(8):777-85. PubMed ID: 15266171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]